Patient-Centered Outcomes Research Trust Fund
Schedules
TAFS: 579-8299 2010/2029 - Patient-Centered Outcomes Research Trust Fund
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1201 | BA: Mand: Appropriation | $293,500,000 | ||
| 1203 | SEQ | BA: Mand: Appropriation (previously unavailable) | $34,941,000 | |
| 1232 | SEQ 1 | BA: Mand: Appropriations temp. reduced, GF | -$16,729,500 | |
| 1232 | SEQ 2 | BA: Mand: Appropriations temp. reduced, IRS Fees | -$20,919,000 | |
| 1232 | SEQ 3 | BA: Mand: Appropriations temp. reduced, Interest | -$10,260 | |
| 1250 | 1 | BA: Mand: Anticipated Appropriation from IRS Fees | $367,000,000 | |
| 1250 | 2 | BA: Mand: Anticipated Appropriation, Interest on TF | $180,000 | See footnotes below |
| Footnotes for line 1250 (2): | B1: The estimate for interest earned assumes a compounded interest rate of .040%. | |||
| 1920 | Total budgetary resources avail (disc. and mand.) | $657,962,240 | ||
| 6011 | Cat B: Patient-Centered Outcomes Research Institute | $526,369,792 | ||
| 6012 | Cat B: Patient-Centered Outcomes Research- HHS (75-X-0145) | $131,592,448 | ||
| 6190 | Total budgetary resources available | $657,962,240 | See footnotes below | |
| Footnotes for line 6190: | A1: Details on sheets other than sheet 1 are not subject to 31 USC 1517. | |||
Footnotes
Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.
| Number | Text |
|---|---|
| A1 | Details on sheets other than sheet 1 are not subject to 31 USC 1517. |
| B1 | The estimate for interest earned assumes a compounded interest rate of .040%. |
Notes about this page
- † Links to public laws are automatically generated and are not guaranteed to be accurate.